“While injectable approaches for Lp(a) are currently in Phase 3 development, including Lilly’s own lepodisiran program, these are the first positive Phase 2 data for an oral approach,” said Ruth ...
Begin your TipRanks Premium journey today. Novo Nordisk (0QIU) Company Description: With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of ...